Helus Pharma CEO to Present at Major Investment Conference
September 9, 2026 — Helus Pharma CEO Michael Halstead to speak at H.C. Wainwright conference Sept 14. Clinical-stage company developing novel mental health treatments.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
GeoVax Applauds New Global Mpox Vaccine Stockpile; GEO-MVA Ready for Phase 3
September 9, 2026 — GeoVax welcomes global mpox vaccine stockpile, highlighting GEO-MVA's readiness for Phase 3 to support diversified supply. Learn about the initiative's impact.
Voyageur Hits Milestone, Gets $1M from Bayer for Iodine
September 9, 2026 — Voyageur Pharmaceuticals achieves first milestone with Bayer, receives $1M for iodine feasibility study, advancing domestic contrast media supply.
Translational Longevity: The Bridge from Lab to Life
September 9, 2026 — Wellness Index Report reveals translational longevity as key to delivering science to patients. Experts discuss breakthroughs and the Translational Longevity Summit in Boston.
August Wellness Index Report: Translational Longevity Takes Center Stage
September 9, 2026 — August Wellness Index Report urges focus on translational longevity—moving lab breakthroughs to patients. Summit in Boston Oct 7-11.
IDR Win Turns Into Court Battle: CollectionPro Helps Provider Pursue $72K Award
September 9, 2026 — CollectionPro highlights a federal IDR win against UnitedHealthcare, where a $72K award went unpaid, leading to court enforcement. Learn about post-award recovery.
Phone Bans Aren't Enough: Expert Reveals What Kids Really Need
September 9, 2026 — Phone bans are spreading, but Dr. Roseann Capanna-Hodge says kids need regulation skills. Her new book, The Dysregulated Kid, offers a playbook for parents.
Creative Biolabs Upgrades Single-Cell Suite for Multi-Omics Research
September 9, 2026 — Creative Biolabs enhances its single-cell profiling suite with advanced RNA sequencing and multi-omics services, empowering researchers in oncology, immunology, and neuroscience.
LiverRight and Aegle Medical Partner to Expand Advanced Liver Care
September 9, 2026 — LiverRight and Aegle Medical Solutions partner to expand non-invasive liver assessment and virtual specialist care across the U.S., improving early diagnosis and treatment.
Tumor Microenvironment Reshapes NK Cells Into Diverse Cancer Fighters
September 9, 2026 — New review reveals tumor microenvironment reshapes NK cells into three distinct subsets, offering fresh targets for more precise cancer immunotherapies and better patient outcomes.
Birmingham OB/Gyn Wins $17,500 to Boost Rural Maternity Care
September 9, 2026 — Birmingham OB/Gyn receives $17,500 ARHTP grant to link its EHR to Alabama One Health Record, improving rural maternity care coordination across Alabama.
Backus Smiles Named Homewood's Best Orthodontist 2026
September 9, 2026 — Backus Smiles and Dr. Dominique Backus named Homewood's Best Orthodontist and Orthodontic Practice 2026 by Homewood Life, reflecting community trust and expert care.
RoC's 2-Step Peel Pads: At-Home Resurfacing Without the Redness
September 9, 2026 — RoC Skincare's new Line Smoothing 2-Step Peel Pads offer at-home chemical peel results with patented clinical retinol, no downtime, and under $2 per treatment. Suitable for sensitive skin.
Nanox Expands ARC Distribution in New England with New Partner
September 8, 2026 — Nanox expands Nanox.ARC distribution in New England via Associated X-Ray Imaging, increasing access to 3D tomosynthesis in outpatient settings.
SS Innovations Expands Globally with SSi Mantra Robotic Surgery
September 8, 2026 — SS Innovations International (SSII) reports 39.4% revenue growth, 224 SSi Mantra systems installed globally, and eyes US and Europe expansion. Learn about the future of surgical robotics.
VERAXA Biotech Appoints Raju Willener as CFO to Drive Capital Strategy
September 8, 2026 — VERAXA Biotech appoints Raju Willener as CFO to lead capital strategy and support BiTAC(R) platform development. Read about his experience and impact on VRXA.
Scinai Immunotherapeutics Refocuses on NanoAb Platform, Drops PC111 Option
September 8, 2026 — Scinai Immunotherapeutics refocuses R&D on NanoAb platform, drops PC111 option, and advances psoriasis program with potential €12M grant. CDMO orders reach $3.1M.
Onco-Innovations Advances ONC010 Toward Clinic with Manufacturing and Capital Milestones
September 8, 2026 — Onco-Innovations advances ONC010 PNKP inhibitor with manufacturing and IND milestones, positioning for clinical trials. Learn about the company's progress and investment potential.
OS Therapies to Present at Moody Capital Conference, Advancing Cancer Treatment for Pets
September 8, 2026 — OS Animal Health, a subsidiary of OS Therapies (NYSE: OSTX), presents at Moody Capital Conference, advancing OST-HER2 for canine osteosarcoma. Learn about this innovative immunotherapy.
Laser Therapy Shows Promise in Brain Cancer Treatment
September 8, 2026 — Discover how laser therapy is improving brain cancer outcomes, with insights from Washington University and CNS Pharmaceuticals. Learn about LITT and its potential.